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Abstract
Background: In 2006, New Jersey was the first state to mandate prenatal education and 
screening at hospital delivery for postpartum depression. We sought to evaluate provision of 
prenatal education and screening at delivery, estimate the prevalence of postpartum depressive 
symptoms, and identify venues where additional screening and education could occur.
Methods: For women who delivered live infants during 2009 and 2010 in New Jersey, data on 
Edinburgh Postnatal Depression Scale scores assessed at hospital delivery and recorded on birth 
records were linked to survey data from the Pregnancy Risk Assessment Monitoring System 
(PRAMS), a population-based survey of mothers completed 2–8 months postpartum (n = 2,391). 
The PRAMS survey assesses postpartum depressive symptoms and whether the woman’s prenatal 
care provider discussed the signs and symptoms of perinatal depression with her, used as a proxy 
for prenatal education on depression.
Results: Two-thirds (67.0%) of women reported that a prenatal care provider discussed 
depression with them and 89.6% were screened for depression at hospital delivery. Among the 
13% of women with depressive symptoms at hospital delivery or later in the postpartum period, 
over a third were Women, Infants, and Children program (WIC) participants, 13% to 32% had an 
infant in the neonatal intensive care unit (NICU), over 80% attended the maternal postpartum 
check-up, and over 88% of their infants attended ≥ 1 well baby visits.
Conclusions: Prenatal education and screening for depression at hospital delivery is feasible and 
results in the majority of women being educated and screened. However, missed opportunities for 
education and screening exist. More information is needed on how to utilize WIC, NICU, and well 
baby and postpartum encounters to ensure effective education, accurate diagnosis, and treatment 
for depressed mothers.
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Introduction
DEPRESSION AFTER THE BIRTH of a child can be debilitating and may have adverse 
consequences for maternal-infant bonding and infant development.1 A recently published 
study among 10,000 women at a Pittsburgh hospital who were screened for depression with 
the Edinburgh Postnatal Depression Scale (EPDS) at 4–6 weeks postpartum found that 14% 
had possible depression, 19% of whom experienced self-harm ideation.2 Although 
postpartum mood disorders, including major depression, are as or more common than mood 
disorders among nonpregnant women, postpartum women are half as likely to seek treatment 
for a mood disorder.3 This statistic is especially discouraging considering that approximately 
half of depressed nonpregnant women of reproductive age do not receive a diagnosis or 
treatment.4,5 Identifying pregnant and postpartum women with depression may be the first 
step toward treatment. However, a 2009 national survey of obstetrician-gynecologist fellows 
found that only 37% reported using a validated screening instrument to detect depression in 
their patients.6
In 2006, through the support of its Governor and in collaboration with the Health 
Department, New Jersey was the first state to enact a law mandating education and screening 
for depression among postpartum women (New Jersey Law N.J.S.A. 26: 2–175 et seq.). The 
law states that prenatal care providers shall provide education to women about postpartum 
depression to increase detection and treatment of the disorder. Additionally, the law specifies 
that “physicians, nurse midwives, and other licensed healthcare professionals providing 
postnatal care to women shall screen new mothers for postpartum depression symptoms 
prior to discharge from the birthing facility and at the first few postnatal check-up visits.” In 
2007, a subcommittee of the NJ Postpartum Depression Task Force recommended using the 
EPDS; most hospitals in New Jersey continue to administer the EPDS during the delivery 
hospitalization. Since 2006, Illinois and West Virginia have implemented similar perinatal 
depression education and screening policies, and several other states have educational 
mandates and awareness campaigns.7
Evaluation of New Jersey’s law could inform decisions by other states in adopting and 
implementing similar comprehensive laws to promote screening and education for 
depression. However, no information has been published on the implementation of such laws 
and we found only one published study examining the effectiveness of New Jersey’s 
mandate8. Therefore, there were three aims of this study: (1) to evaluate provision of 
prenatal education and screening for depression at hospital delivery; (2) to assess the 
prevalence of depressive symptoms experienced postpartum; and (3) to identify possible 
venues where additional education and screening services could take place. This information 
may inform clinicians, public health practitioners, and policymakers in New Jersey and other 
states implementing or considering similar laws of the feasibility of providing prenatal 
education and screening at hospital delivery and the need for additional education and 
screening for perinatal depression at venues that serve the needs of postpartum women and 
their infants.
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Materials and Methods
Data sources
For women who delivered live infants during 2009 and 2010 in New Jersey, data on EPDS 
scores assessed at hospital delivery and recorded on confidential birth certificate records 
were linked to survey data from the Pregnancy Risk Assessment Monitoring System 
(PRAMS). PRAMS is an annual population-based, self-reported survey of postpartum 
women that assesses maternal behaviors and experiences before, during, and after pregnancy 
(www.cdc.gov/PRAMS). Each year, a stratified sample of mothers who delivered live infants 
in New Jersey was selected from birth certificate records. Women were mailed a 
questionnaire typically 2–3 months after delivery. New Jersey PRAMS staff attempt to 
contact nonresponders through two additional mailed questionnaires and up to 15 phone 
calls up to 9 months after delivery. The overall PRAMS response rate in New Jersey for 
2009 and 2010 was 72.6% and 73.2%, respectively.
Depression data and screening instruments
As stated previously, New Jersey hospitals use the EPDS to screen for depressive symptoms 
at delivery. Both ≥ 10 and ≥ 12 are cutoff scores recommended to providers by the NJ 
Department of Health. For analytic purposes, we used a cutoff score of ≥ 10 on the EPDS to 
indicate a positive screen for depression. For a cutoff score of ≥ 10 on the EPDS, the 
sensitivity ranges from 59% to 81% and specificity ranges from 77% to 88% depending 
upon the sample.9
The New Jersey PRAMS survey assessed women’s self-report of whether the healthcare 
provider discussed prenatal and postpartum depression with the woman during her 
pregnancy with the question, “During your pregnancy, did your healthcare provider discuss 
with you what to do if you feel depressed during pregnancy or after your baby is born?” In 
addition, the PRAMS survey used a three-item screener to assess maternal depressive 
symptoms since the birth of the baby. The three items included: “I have felt down, depressed 
or sad,” “I have felt hopeless,” and “I have felt slowed down physically.” Categorical 
responses were based on the frequency of experiencing these feelings since the woman’s 
new baby was born. Responses and their associated numerical values included “never” (1), 
“rarely” (2), “sometimes” (3), “often” (4), or “always” (5). When the sum of the responses 
totaled ≥ 10, the woman was considered to have postpartum depressive symptoms, which is 
the recommended cutoff for surveillance purposes based on findings from a validation study 
of the screening instrument.10 The sensitivity and specificity of this algorithm for 
postpartum depression has been reported as 57% and 87%, respectively.10
Additional analytic variables
Maternal demographic and infant characteristics examined in this analysis were derived 
from both the birth certificate and the PRAMS survey. Items from the birth certificate 
included maternal age, education, race/ethnicity, and gestational age. Items from the 
PRAMS survey included insurance status, participation in the Women, Infants, and Children 
(WIC) program, infant admission to the neonatal intensive care unit (NICU), and attendance 
at well-baby visits and the mother’s postpartum check-up.
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Statistical analyses
To evaluate our first aim—implementation of the state mandate—we examined both the 
percent of women who reported discussing with their provider what to do if they feel 
depressed during pregnancy or after their baby is born, as a proxy for prenatal education on 
depression, and prevalence of receipt of screening for depression at hospital delivery. For the 
analysis on prenatal education on depression, we limited the analysis to women who 
attended one or more prenatal care visits. For both analyses, we used chi-squared tests to 
examine whether prevalence differed by maternal demographic and infant characteristics.
To assess the second aim—prevalence of postpartum depressive symptoms—we calculated 
prevalence estimates for screening positive for depression at delivery hospitalization and for 
screening positive for depressive symptoms at 2–9 months postpartum. We also examined 
the extent of overlap between the two.
To fulfill our third aim, identifying additional venues where maternal education and 
screening for depression could take place, we examined participation in the WIC program, 
infant admission to the NICU, and attendance at well-baby visits and the mother’s 
postpartum check-up. All data were weighted for sample design, nonresponse, and 
noncoverage to produce estimates representative of the New Jersey population. The Centers 
for Disease Control and Prevention institutional review board (IRB) approved the PRAMS 
protocol and the New Jersey Department of Health’s IRB approved the use of the EPDS 
birth certificate data for use in this analysis.
Results
Sample
The EPDS scores assessed at hospital delivery were entered into the electronic birth 
certificate record by 42 of 53 (79.2%) New Jersey maternity hospitals, allowing coverage of 
81.3% of PRAMS interviews in 2009–2010 (n = 2,391; Fig. 1). Of the 2,391 women, 272 
(11.4%) were missing an individual EPDS score. Of women with an EPDS score at delivery, 
107 (5.1%) were missing values for the three-item PRAMS depression screener. Therefore, a 
total of 2,012 women (84.1%) were included in analyses using both the delivery and 
postpartum depressive symptom scores, which represents 145,595 New Jersey women. 
Compared with the 2,391 PRAMS participants who delivered their infant in hospitals 
reporting EPDS scores to the NJ Health Department, the 550 PRAMS participants who 
delivered in hospitals not reporting an EPDS score to the NJ Health Department were more 
likely to be less than 25 years of age, have less than a high school education, be African 
American, have Medicaid insurance, and report 6–13 prenatal stressful life events (chi 
square p-value < 0.05 for all); there was no difference in postpartum depressive symptoms. 
Women in our analytic sample completed the PRAMS questionnaire at a median of 3.8 
months after the birth of their child (range: 2.5 to 8 months).
Implementation of the mandate
Prenatal education on depression (reporting that a healthcare provider discussed with the 
woman what to do if she feels depressed during pregnancy or after her baby is born) was 
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reported by 67.0% of the 2,280 women who attended one or more prenatal care visits (Table 
1). However, report of prenatal education on depression ranged from 56.0% among women 
of races/ethnicities other than white, black or Hispanic, to 76.2% among women under 25 
years of age. Women who were under 25 years of age, those with less education, women 
with Medicaid insurance, those with more prenatal stressful life events, women who wanted 
their child later, and those who had a preterm birth were significantly more likely than their 
counterparts to report that their prenatal care provider discussed perinatal depression with 
them (chi square p-value < 0.05 for all; Table 1). Report of prenatal education on depression 
did not vary by year of infant birth (Table 1) and women’s depression screening scores at 
delivery or postpartum (data not shown).
We found that 89.6% of women were screened for depression at hospital delivery (Table 1). 
Receipt of screening at delivery ranged from 85.2% among non-Hispanic black women to 
92.1% among Hispanic women. Women giving birth in 2010, compared to 2009, those with 
full-term infants, and non-Hispanic white or Hispanic women were most likely to be 
screened compared to their counterparts (chi square p-value < 0.05 for all). Receipt of 
screening did not vary by maternal age, education, pregnancy intention, number of prenatal 
stressful life events, and infant admission to the NICU.
Prevalence of postpartum depressive symptoms
Of the 2,012 women in our analytic sample with depressive screening scores at hospital 
delivery and postpartum, 5.5% scored ≥ 10 on the EPDS at delivery hospitalization and 
9.0% scored ≥ 10 on the PRAMS screener postpartum (Table 2). Overall, 87.1% of women 
screened negative at both delivery and postpartum, 3.9% screened positive at delivery and 
negative postpartum, 7.4% screened negative at delivery and positive postpartum, and 1.6% 
screened positive at both time points. Of the 94.5% (weighted n = 130,236) of women who 
screened negative on EPDS at delivery, 7.8% (weighted n = 10,209) reported depressive 
symptoms postpartum.
Venues for additional education and screening
Of the three groups of women with a positive screen at delivery and/or postpartum, 36.8% to 
53.5% participated in the WIC program, 13.4% to 32.5% had an infant admitted to the 
NICU, 88.3% to 94.3% attended the first-week infant well-baby visit, 95.2% to 99.6% 
attended one or more well baby visits at 1, 2, 4, or 6 months, and 80.3% to 88.4% attended 
the maternal postpartum check-up (Table 3).
Discussion
Based on our findings on implementation of the law, New Jersey’s mandate of universal 
prenatal education on depression and screening for depressive symptoms at hospital delivery 
is feasible and results in the majority of women being educated and screened. Overall, we 
found that in 2009 and 2010, two-thirds of women delivering live births in NJ hospitals that 
reported EPDS data to the NJ Health Department reported that their prenatal care provider 
discussed with them what to do if she feels depressed during pregnancy or after her baby is 
born and over 89% were screened for depressive symptoms at delivery hospitalization. 
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Regarding prenatal education on depression, the percentage of women who reported 
discussing the signs and symptoms of depression with their prenatal healthcare provider 
differed by maternal and infant characteristics. Reported rates of prenatal education on 
depression were lowest among women of “other” racial/ ethnic groups, at 56%. A better 
understanding is needed as to whether language, cultural barriers, or other issues are 
responsible for the low percentage. Percentages of women reporting prenatal education were 
also significantly lower among older women, women with more education, those with 
private insurance, women with fewer reported stressful life events, and those delivering full-
term infants. While these groups of women may have a lower risk of depression during and 
after pregnancy, up to 12% screened positive on one or both depression screeners (data not 
shown). In regard to depression screening at hospital delivery, rates improved from 2009 
(87.8%) to 2010 (91.3%), and varied by race/ethnicity and infant gestational age at birth, 
with non-Hispanic black women and women with preterm infants having the lowest point 
prevalence of screening compared to their counterparts. Further research is needed as to why 
these disparities in screening exist.
Published reports from the Oregon Health Authority (http://public.health.oregon.gov/
HealthyPeopleFamilies/DataReports/prams/2010/Pages/dodepr.aspx) and the Alabama 
Department of Health (www.adph.org/healthstats/assets/PRAMS2010.pdf) show that New 
Jersey’s estimate of prenatal education on depression is in line with other states (Oregon: 
77%; Alabama: 66%). For women who reported no prenatal education on depression, their 
clinicians may not have educated them about depression due to lack of time, resources, or 
knowledge on the topic, or women may not recall the counseling they received. It is possible 
that some clinicians provide educational reading materials to all women, but only discuss 
depression with women at high risk or those who screen positive. However, discussing the 
signs and symptoms of depression before symptoms begin may help women identify their 
symptoms and seek care before symptoms become severe. Regardless, there are missed 
opportunities for effectively educating all women about the signs and symptoms of 
postpartum depression and how to seek help when needed. More information is needed on 
the prevalence, best practice approach, and effectiveness of clinicians educating their 
pregnant patients on depression, especially from states that mandate this type of education.
There is limited published data on rates of screening for depression at hospital delivery. 
Although it is difficult to compare between studies due to different denominators and study 
designs, this figure is higher than reported rates of screening for depressive symptoms using 
a validated screening instrument at the maternal postpartum visit.6,11,12 In a 2009 national 
survey of obstetrician-gynecologist fellows agreeing to participate in surveys, only 37% 
reported routinely using a validated screening instrument to screen for postpartum 
depression.6 An earlier national survey, published in 2003, found that only 12% of new 
obstetrician- gynecologists and current residents identified their most recent patient with 
postpartum depression through routine questioning and screening results.12 At an academic 
hospital in North Carolina, postpartum care providers documented depression screening in 
only 39% of visits.11
A substantial percentage of New Jersey mothers experienced postpartum depressive 
symptoms, signifying a need for continued education and screening. In our sample of New 
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Jersey women with recent live births, 13% screened positive for depressive symptoms at 
delivery and/or during the postpartum period, which is similar to a recent estimate of 
postpartum depressive symptoms.2 Of importance is the fact that over 7% of women who 
screened negative at hospital delivery screened positive for depressive symptoms between 2 
and 8 months postpartum, which represents over 10,000 NJ mothers. The lack of agreement 
between the screening results at delivery and postpartum could be due to depressive 
symptoms beginning or resolving, with or without treatment, between hospital discharge and 
completion of the PRAMS survey due to changing demands on the mother across the first 
year postpartum; as well as differences in the questions asked, time periods covered, and 
binary cutoffs used between screeners; and the less than 100% sensitivity and specificity of 
the screeners.
Additional venues exist for education and depression screening during the postpartum 
period. The American College of Obstetricians and Gynecologists strongly encourages 
providers to screen for postpartum depression.13 The American Academy of Pediatrics 
recommends screening for maternal depression at the 1-, 2-, 4-, and 6-month well-child 
visits.14 New Jersey law mandates screening for postpartum depression at delivery prior to 
discharge and during postpartum maternal care. We did not have information on prevalence 
of screening for depression, or screening results, at the postpartum obstetric visit. As noted 
previously, other studies have reported low rates of using a validated screening instrument to 
detect postpartum depression.6,11,12 Additionally, up to 20% of women with depression at 
delivery and/or postpartum did not attend their maternal postpartum visit. In addition to 
obstetric visits, pediatric appointments, WIC visits, and NICU encounters are opportunities 
for education and subsequent screening. In this sample, over 95% of women’s infants 
attended at least one well-baby visit; a third to a half were WIC participants, and 13 to 32% 
had infants admitted to the NICU. Strengthening screening protocols may be needed to take 
advantage of women’s interactions with clinical and social services.
However, screening alone is insufficient to ensure depressed mothers receive appropriate 
care. The U.S. Preventive Services Task Force recommends that screening adults for 
depression must be coupled with procedures to ensure accurate diagnosis and treatment.15 
Kozhimanill et al. found that among NJ mothers covered by Medicaid, there was no change 
in documented treatment after the enactment of the law.8 The authors concluded that 
additional efforts may be needed to ensure depressed women get treatment, such as ways to 
monitor and enforce the screening requirement, paying providers to screen and follow-up 
with women, and further research on effective interventions for depressed women. 
Connecting women to care is often difficult; barriers to treatment among pregnant women 
include cost and lack of insurance, opposition to treatment, stigma, and transportation and 
childcare issues5. Long wait times and lack of mental health providers also hinder receipt of 
treatment. Providing mental health services onsite has been shown to increase treatment 
utilization,16 but may not be feasible for all obstetric practices. Effective and efficient 
processes are needed to ensure that women who screen positive receive further assessment 
and treatment if needed.
This analysis has some limitations. The EPDS and PRAMS depression screeners detect 
depressive symptoms and have less than 100% sensitivity and specificity for identifying 
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depression. Therefore, some women may have been inaccurately categorized. The data are 
not fully representative of all NJ mothers with live births, since 11 hospitals (18.7% of 
PRAMS-eligible births in 2009–2010) throughout the state did not provide data on EPDS 
score at delivery hospitalization to the NJ Department of Health. Differences were found 
between these groups of women, but it is difficult to evaluate whether the exclusions led to 
over- or underestimating the prevalence of screening or depressive symptoms at delivery. We 
did not have information on prevalence of depression screening at the maternal postpartum 
visit, nor did we have information on provision of educational materials on perinatal 
depression, limiting our ability to evaluate the mandate fully.
Conclusions
In summary, we found that the large majority of women delivering an infant in a New Jersey 
hospital included in our sample were screened for postpartum depression at hospital delivery 
and two-thirds reported receiving prenatal education on the signs and symptoms of 
depression. Additionally, a substantial percentage of women experienced depressive 
symptoms after delivery hospitalization, signaling a need for additional education and 
screening at other time points. Possible venues for education and screening for depression 
may include WIC and NICU encounters and well-baby visits. Additionally, more 
information is needed on how NJ hospitals and obstetric healthcare providers have 
implemented the education and screening mandates and what can be done to ensure accurate 
diagnosis and treatment for women who need it.
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FIG. 1. 
Linked data, sample sizes, and unweighted percentages from the Pregnancy Risk 
Assessment Monitoring System (PRAMS) and birth certificate records. EPDS, Edinburgh 
Postnatal Depression Scale.
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TABLE 2.
DEPRESSION SCREENING RESULTS AT DELIVERY HOSPITALIZATION AND BETWEEN 2 AND 8 MONTHS POSTPARTUM
Postpartumb
Deliverya Positive Negative Total
% (95% CI) % (95% CI) % (95% CI)
Positive 1.6 (1.1, 2.3) 3.9 (3.1, 4.9) 5.5 (4.6, 6.7)
Negative 7.4 (6.3, 8.8) 87.1 (85.4, 88.6) 94.5 (93.3, 95.4)
Total 9.0 (7.8, 10.5) 91.0 (88.5, 92.2) 100
n = 2,012.
a
Depressive symptoms at delivery hospitalization based on Edinburgh Postnatal Depression Scale.
b
Depressive symptoms postpartum based on Pregnancy Risk Assessment Monitoring System questionnaire filled out by the mother between 2 to 8 
months postpartum.
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